Biodesix Valuation
| BDSX Stock | USD 1.33 0.05 3.91% |
Today, the firm appears to be undervalued. Biodesix shows a prevailing Real Value of $2.03 per share. The current price of the firm is $1.33. Our model approximates the value of Biodesix from analyzing the firm fundamentals such as Return On Equity of -3.32, profit margin of (0.67) %, and Current Valuation of 224.02 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Biodesix's valuation include:
Price Book 6.9452 | Enterprise Value 224 M | Enterprise Value Ebitda (2.72) | Price Sales 2.951 | Enterprise Value Revenue 3.4169 |
Undervalued
Today
Please note that Biodesix's price fluctuation is very risky at this time. Calculation of the real value of Biodesix is based on 3 months time horizon. Increasing Biodesix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biodesix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biodesix Stock. However, Biodesix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.33 | Real 2.03 | Target 4.25 | Hype 1.33 | Naive 1.33 |
The intrinsic value of Biodesix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biodesix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biodesix helps investors to forecast how Biodesix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biodesix more accurately as focusing exclusively on Biodesix's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Biodesix's intrinsic value based on its ongoing forecasts of Biodesix's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Biodesix's closest peers.
Biodesix Cash |
|
Biodesix Valuation Trend
Analysing the historical paterns of Biodesix's enterprise value and its market capitalization is a good way to estimate and gauge the value of Biodesix over time and is usually enough for investors to make rational market timing decisions.
Biodesix Total Value Analysis
Biodesix is currently projected to have valuation of 224.02 M with market capitalization of 193.47 M, debt of 60.69 M, and cash on hands of 15.18 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biodesix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
224.02 M | 193.47 M | 60.69 M | 15.18 M |
Biodesix Investor Information
About 47.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.37. Biodesix had not issued any dividends in recent years. Based on the key measurements obtained from Biodesix's financial statements, Biodesix is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Biodesix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biodesix has an asset utilization ratio of 49.53 percent. This suggests that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Biodesix is more efficient with each dollar of assets it utilizes for everyday operations.Biodesix Ownership Allocation
Biodesix holds a total of 145.47 Million outstanding shares. Biodesix retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Biodesix Profitability Analysis
The company reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M.About Biodesix Valuation
Our relative valuation model uses a comparative analysis of Biodesix. We calculate exposure to Biodesix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biodesix's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 36.1 M | 26.1 M | |
| Pretax Profit Margin | (1.06) | (1.12) | |
| Operating Profit Margin | (0.84) | (0.88) | |
| Net Loss | (1.06) | (1.12) | |
| Gross Profit Margin | 0.73 | 0.70 |
Biodesix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 82.1 M |
Biodesix Current Valuation Indicators
Valuation refers to the process of determining the present value of Biodesix and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Biodesix we look at many different elements of the entity such as Biodesix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Biodesix, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Biodesix's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Biodesix's worth.Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.